In this On Target podcast, Dr Akila Viswanathan talks with Dr Robert Timmerman from UT Southwestern about radiation therapy for oligometastatic disease as part of our series for Seminars in Radiation Oncology.
In this On Target podcast, Dr Akila Viswanathan speaks with Dr Sahaja Acharya, Director of Pediatric Radiation Oncology, about treating children with brain tumors.
In this On Target podcast, Dr Akila Viswanathan and Dr Aditya Halthore discuss the treatment of patients with lung and genitourinary cancers at the Johns Hopkins Proton Therapy Center located at Sibley Memorial Hospital in Washington DC.
In this On Target podcast, Dr Akila Viswanathan speaks with Dr Philipp Oberdoerffer about his research on how cells function or stop functioning, and how that can result in diseases like cancer.
Dr Akila Viswanathan talks with Dr Wilfred Ngwa about both his work as the Director of the Global Health Catalyst, which aims to reduce cancer health disparities around the world, and his research pairing medical physics with immunotherapy. Learn more at globalhealthcatalystsummit.org
Dr Akila Viswanathan talks with Dr Curtiland Deville, the Medical Director of the Johns Hopkins Proton Therapy Center, and Dr Heng Li, the Chief Proton Physicist of the Johns Hopkins Proton Therapy Center, about treatment options and research potential for proton therapy.
Dr Akila Viswanathan speaks with Dr Ramesh Rengan and Dr Jing Zeng, both from the Department of Radiation Oncology at the University of Washington Medicine, about treatment advances in non small-cell lung cancer for Seminars Radiation Oncology.
In this On Target podcast, Dr Akila Viswanathan talks with Dr Ana Kiess from Johns Hopkins and Dr John Buatti from the University of Iowa to review the latest edition of Seminars in Radiation Oncology focusing on ‘Theranostics,’ the combining of therapeutic and diagnostic radiopharmaceuticals.
In this On Target podcast, Dr Akila Viswanathan and the COVID-19 response team from the Department of Radiation Oncology and Molecular Radiations Sciences provide an update on our response to the COVID-19 pandemic.
